Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum HAVN Life Sciences C.HAVN

Alternate Symbol(s):  HAVLD

HAVN Life Sciences Inc is a biotechnology company engaged in the business of the research and development of psycho-pharmacological products, including the formulation of standardized psychoactive compounds derived from fungi. The products of the company will help to improve mental health and human performance.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

You have a lot of explaining to do HAVN

HAVN Life Sciences have a lot of explaining to do as to why their share trading is suspended. For starters the BC and Ontario Securities Commissions didn't explain why their shares have more

HAVN .... Halted

Start the drumroll No position  rate and reply

Imagine Lithium Identifies a New Drilling Target Located Near Flagship Jackpot Property

J.C. St-Amour, President of Imagine commented, "This newly discovered area demonstrates the prospectivity of our very large land package. The team is very excited to test this newly identified zone. There is some ground cover in this area, so there is excellent potential for expansion of this dike along strike as well as potential for additional dikes in this area. The grab sample grades suggest it is a well mineralized dike that we intend to drill test in 2023." more

How do they keep the lights on?

What are they doing to shore up this disaster. Microdosing is slowly being adopted. It would like to see this sinking ship turn around.  rate and reply

Tim Moore has hung us out to dry.

30:1 consolidation, I am an idiot to have bought this deal in the first place and a bigger idiot to have ridden down 90+ percent to absolute pennies, today's pre-consolidation is $ 0.042 more

HAVN Life Announces 30:1 Consolidation of Common Shares  rate and reply

look into $NIRV

I'd drop this turd and look more into $NIRV, alot better management and newly listed.  rate and reply

RE:RE:RE:News Update w Radius Research and $HAVN CEO Tim Moore

hopefully these guys are not doing a 1 for 50 split like myco. What a killer that is.  rate and reply

RE:RE:News Update w Radius Research and $HAVN CEO Tim Moore

Something strange going on. Price was 0.125 the day they announced share sale. Price drops to .05 before share sale closed. 2 days later share sale closes for $2mm cash injection at .087 per share more

RE:News Update w Radius Research and $HAVN CEO Tim Moore

what the hell just happened with this stock price?  rate and reply

HAVN Announces Termination of Amalgamation Agreement...

to Acquire Spore Life Sciences...  rate and reply

Distribution Agreement with Mycrodose Therapeutics

The Agreement allows HAVN Life to export naturally derived psilocybin from its Jamaica facility and grows roster of supply partners in the U.S. market VANCOUVER, BC, Feb. 10, more

News Update w Radius Research and $HAVN CEO Tim Moore

News Update: HAVN Life Sciences (HAVN) w CEO Tim Moore - Mycrodose Therapeutics Distribution - {^youtubevideo|(width)425|(height)264|(rel) more

A slow death. When to they close their doors?

No revenue, No business.   rate and reply

RE:C.HAVN News - Aquisition of US company

This is a slow to market sector. The future is solid but the time line of ONE year is realistic. Have been in the deal for some time now, had thought we would be further down the road, BUT, their more

C.HAVN News - Aquisition of US company

By Shadd Dales On Feb 1, 2022 Havn Life Sciences (CNSX: HAVN) (OTCMKTS: HAVLF) CEO Tim Moore recently caught up with The Dales Report after a long absence from the podcast, with an update on more